IP Library Granted Patent US 8,470,593
Granted Patent B2
US 8,470,593 · App. 13/275,746 · Granted Jun 25, 2013

Plasmid system for multigene expression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,470,593
App. No.
13/275,746
Granted
Jun 25, 2013
Kind
B2
Abstract

The present invention provides a plasmid system which facilitates the construction of a single amplifiable plasmid that, having the potential to accommodate many independent expression cassettes, has the ability to express multi-subunit complex proteins such as antibodies and receptors.

Claims (10)

1. An isolated host cell comprising a recombined amplifiable vector which is the product of a method comprising:

(a) introducing one or more expression cassettes into a first multiple cloning site of a first universal transfer vector wherein said first universal transfer vector comprises the plasmid map set forth in FIG. 2 ; wherein the first multiple cloning site comprises nucleotides 620-766 of the nucleotide sequence set forth in SEQ ID NO: 2; and wherein said first multiple cloning site is in said orientation or in a reverse orientation;

(b) introducing one or more expression cassettes, different from the cassettes introduced into said first universal transfer vector, into a second multiple cloning site of a second universal transfer vector which second multiple cloning site comprises nucleotides 620-772 of the nucleotide sequence set forth in SEQ ID NO: 1; wherein said second multiple cloning site is in said orientation or in a reverse orientation; and

(c) introducing said cassettes from steps (a) and (b) into a third multiple cloning site of an amplifiable vector; wherein said amplifiable vector comprises the plasmid map set forth in FIG. 3 ; wherein said third multiple cloning site comprises nucleotides 5037-5183 of the nucleotide sequence set forth in SEQ ID NO: 3; wherein said third multiple cloning site is in said orientation or in a reverse orientation; and

(d) introducing said amplifiable vector comprising said cassettes from steps (a) and (b) into a host cell.

2. An isolated host cell comprising a recombined amplifiable vector which comprises the nucleotide sequence set forth in SEQ ID NO: 26 which is the product of a method comprising:

(a) introducing one or more expression cassettes into a first multiple cloning site of a first universal transfer vector which first multiple cloning site comprises nucleotides 620-766 of the nucleotide sequence set forth in SEQ ID NO: 2; wherein said first multiple cloning site is in said orientation or in a reverse orientation;

(b) introducing one or more expression cassettes, different from the cassettes introduced into said first universal transfer vector, into a second multiple cloning site of a second universal transfer vector which second multiple cloning site comprises nucleotides 620-772 of the nucleotide sequence set forth in SEQ ID NO: 1; wherein said second multiple cloning site is in said orientation or in a reverse orientation; and

(c) introducing said cassettes from steps (a) and (b) into a third multiple cloning site of an amplifiable vector wherein said third multiple cloning site comprises nucleotides 5037-5183 of the nucleotide sequence set forth in SEQ ID NO: 3; wherein said third multiple cloning site is in said orientation or in a reverse orientation; and

(d) introducing said amplifiable vector comprising said cassettes from steps (a) and (b) into a host cell.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →